Abstract
Treatment of the superficial femoral artery (SFA) has been among the least effective of all endovascular procedures in terms of long-term patency. The relatively small vessel lumen, in conjunction with a high plaque burden, slow flow, and a high frequency of primary occlusions, contributes to a considerable rate of acute technical failures. Because of these technical limitations a much effort has been made during the past years. This manuscript should summarize the hopes and limitations of different approaches such as brachytherapy, cutting balloons, stents and stent grafts, drug-eluting stents, and drug-coated balloons.
Similar content being viewed by others
References
Transatlantic Intersociety Consensus Group (2000) Management of peripheral arterial disease (PAD). Transatlantic Inter-Society Consensus (TASC). Eur J Vasc Endovasc Surg 19 [Suppl A]:Si–Sxxviii, S1–S250
Cheng SW, Ting AC, Wong J (2001) Endovascular stenting of superficial femoral artery stenosis and occlusions: results and risk factor analysis. Cardiovasc Surg 9:133–140
Minar E, Ahmadi RA, Ehringer H, Marosi L, Czembirek H, Konecny U (1986) Percutaneous transluminal angioplasty (PTA) in peripheral arterial occlusive disease of the lower extremities (in German). Wien Klin Wochenschr 98:33–40
Duda SH, Poerner TC, Wiesinger B, Rundback JH, Tepe G, Wiskirchen J, Haase, KK (2003) Drug-eluting stents: potential applications for peripheral arterial occlusive disease. J Vasc Interv Radiol 14:291–301
Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Mudde C, Tielemans H, Beregi JP (2005) Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 16:331–338
Grenacher L, Saam T, Geier A, Muller-Hulsbeck S, Cejna M, Kauffmann GW, Richter GM (2004) PTA versus Palmaz stent placement in femoropopliteal artery stenoses: results of a multicenter prospective randomized study (REFSA) (in German). Rofo Fortschr Geb Rontgenstr Neuen BildgebVerfahr 176:1302–1310
Herzog C, Grebe C, Mahnken A, Balzer JO, Mack MG, Zangos S, Ackermann H, Schaller S, Seifert T, Ohnesorge B, Vogl TJ (2005) Peripheral artery stent visualization and in-stent stenosis analysis in 16-row computed tomography: an in-vitro evaluation. Eur Radiol 15:2276–2283
Mewissen MW (2004) Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results. Tech Vasc Interv Radiol 7:2–5
Vogel JH (1994) Stents: a time for clinical judgment. J Am Coll Cardiol 24:1213
Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A, Wiesinger B, Hak JB, Tielemans H, Ziemer G, Cristea E, Lansky A, Beregi JP (2002) Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 106:1505–1509
Tepe G, Schmehl J, Claussen CD, Ernemann U, Pereira P, Duda SH (2005) Drug coated stents for carotid intervention. J Cardiovasc Surg (Torino) 46:249–259
Toutouzas K, Di Mario C, Falotico R, Takagi T, Stankovic G, Albiero R, Corvaja N, Colombo A (2002) Sirolimus-eluting stents: a review of experimental and clinical findings. Z Kardiol 91 [Suppl 3]:49–57
Scheinert D, Scheinert S, Sax J, Piorkowski C, Braunlich S, Ulrich M, Biamino G, Schmidt A (2005) Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45:312–315
Ahmadi R, Schillinger M, Maca T, Minar E (2002) Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent graft. Radiology 223:345–350
Bray PJ, Robson WJ, Bray AE (2003) Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent graft. J Endovasc Ther 10:619–628
Saxon RR, Coffman JM, Gooding JM, Natuzzi E, Ponec DJ (2003) Long-term results of ePTFE stent graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol 14:303–311
Deutschmann HA, Schedlbauer P, Berczi V, Portugaller H, Tauss J, Hausegger KA (2001) Placement of Hemobahn stent grafts in femoropopliteal arteries: early experience and midterm results in 18 patients. J Vasc Interv Radiol 12:943–950
Grassl ED, Bischof JC (2005) In vitro model systems for evaluation of smooth muscle cell response to cryoplasty. Cryobiology 50:162–173
Fava M, Loyola S, Polydorou A, Papapavlou P, Polydorou A, Mendiz O, Joye JD (2004) Cryoplasty for femoropopliteal arterial disease: late angiographic results of initial human experience. J Vasc Interv Radiol 15:1239–1243
Ansel GM, Sample NS, Botti IC Jr, Tracy AJ, Silver MJ, Marshall BJ, George BS (2004) Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia. Catheter Cardiovasc Interv 61:1–4
Cejna M (2005) Review on principles and background of use in peripheral arteries. Cardiovasc Intervent Radiol 28:400–408
Engelke C, Sandhu C, Morgan RA, Belli AM (2002) Using 6-mm cutting balloon angioplasty in patients with resistant peripheral artery stenosis: preliminary results. AJR Am J Roentgenol 179:619–623
Böttcher HD, Schopohl B, Liermann D, Kollath J, Adamietz IA (1994) Endovascular irradiation—a new method to avoid recurrent stenosis after stent implantation in peripheral arteries: technique and preliminary results. Int J Radiat Oncol Biol Phys 29:183–186
Liermann D, Böttcher HD, Kollath J, Schopohl B, Strassmann G, Strecker EP, Breddin KH (1994) Prophylactic endovascular radiotherapy to prevent intimal hyperplasia after stent implantation in femoropopliteal arteries. Cardiovasc Intervent Radiol 17:12–16
Liermann DD, Bauernsachs R, Schopohl B, Bottcher HD (1997) Five year follow-up after brachytherapy for restenosis in peripheral arteries. Semin Interv Cardiol 2:133–137
Pokrajac B, Pötter R, Maca T, Fellner C, Mittlböck M, Ahmadi R, Seitz W, Minar E (2000) Intraarterial (192)Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2 trial radiotherapy parameters and risk factors analysis. Int J Radiat Oncol Biol Phys 48:923–931
Pokrajac B, Potter R, Wolfram RM, Budinsky AC, Kirisits C, Lileg B, Mendel H, Sabeti S, Schmid R, Minar E (2005) Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study. Radiother Oncol 74:3–9
Wolfram RM, Budinsky AC, Pokrajac B, Potter R, Minar E (2005) Vascular brachytherapy with 192Ir after femoropopliteal stent implantation in high-risk patients: twelve-month follow-up results from the Vienna-5 trial. Radiology 236:343–351
Wolfram RM, Budinsky AC, Pokrajac B, Potter R, Minar E (2005) Endovascular brachytherapy: restenosis in de novo versus recurrent lesions of the femoropopliteal artery—the Vienna experience. Radiology 236:338–342
Scheller B, Speck U, Abramjuk C, Bernhardt U, Bohm M, Nickenig G (2004) Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 110:810–814
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tepe, G., Schmehl, J., Heller, S. et al. Superficial femoral artery: current treatment options. Eur Radiol 16, 1316–1322 (2006). https://doi.org/10.1007/s00330-005-0111-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-005-0111-3